Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
Holders of 5% or more of BHST
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bioharvest Sciences Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Bioharvest Sciences Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Bioharvest Sciences Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 20255:26 PM ET | Rakib Vivien | 13G | 0.00%0 shares | NewBelow 5% | Aug 13, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bioharvest Sciences Inc. shares.
No Form 144 notices for Bioharvest Sciences Inc. are on file.